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Thiosemicarbazones (TSCs) as excellent metal chelators are a class of organic compounds 
with structural diversity and broad spectrum of pharmacological activities, such as 
antiproliferative, antiviral, antibacterial, antimalarial and antifungal effect [1]. Also, their metal 
complex can be more active than the free ligand, and some side effects may decrease upon 
complexation. In addition, the complex can exhibit bioactivities, which are not shown by the 
free ligand. Previously, a tridentate estrone-salicylaldehyde TSC hybrid molecule (estrone-
TSC) was developed in addition to an analogous bicyclic derivative (thn-TSC), which were 
cytotoxic against the hormone-responsive MCF-7 breast cancer cell lines (IC50: thn-TSC: 3.7 
μM, estrone-TSC: 6.4 μM). Their Cu(II) complexes showed more significant cytotoxicity than 
the ligands as 1-2 orders of magnitude lower IC50 values were obtained for the complexes 
against a series of human cancer cell lines [2]. Disubstitution of the terminal NH2 groups in 
case of several α-N-pyridine thiosemicarbazones could result in highly increased anticancer 
activity (e.g. dimethylated Triapine, DpC, Dp44mT) [3]. Based on this finding in this work the 
N-terminally mono- and dimethylated derivatives of estrone-TSC and thn-TSC (Chart 1) and 
their Cu(II) complexes were aimed to prepare to obtain more effective compounds. 
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The solution stability and structure of the complexes were determined using UV-visible 
spectrophotometry and electron paramagnetic resonance spectroscopy. Due to the limited water 
solubility of the compounds UV-titrations were performed in a 30% (v/v) DMSO/H2O solvent 
mixture in order to determine the pKa values of the ligands and the stability constants of the 
complexes. Additionally, their anticancer activity was studied via in vitro cytotoxicity and ROS 
generation assays, and the cell proliferation, apoptosis and its caspase-dependence were also 
screened on 3D cancer spheroids, which are considered to mimic better the main features of 
human solid tumours compared with traditional 2D cultures. 
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